VIPR1 and urinary bladder carcinoma: We found that administration of VIP to bladder cancer cells cultured in vitro led to decreased cell growth, suggesting that the presence of VIP plays a role in regulating bladder cancer cell proliferation, at least in part through VPAC1 receptor.